Navigation Links
PIP in Biological Technology

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

... ANNAPOLIS, Md., Aug. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Admini...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast

... ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 ...

PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009

... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

... ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase I...

PharmAthene Announces $5.5 Million Public Equity Offering

... ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that certain institutional investo...

PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009

... ANNAPOLIS, Md., March 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting

...atric Investigation Plan (PIP) Advisory from PAREXEL Consulting, with an update and guidance on how biopharmaceutical companies should address the new pip requirements, will be provided at PAREXEL's Booth #1522 . PAREXEL experts will also be available at the booth to hold exclusive executive briefings w...

PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008

... ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)

...ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced results from a pilot study showing...

PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases

...acea Biotec to Make a $13.1 Million Strategic Investment in PharmAthene ANNAPOLIS, Md., Sept. 30 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has entered into a strateg...

PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program

... ANNAPOLIS, Md., Sept. 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the National Institute of All...

PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008

... ANNAPOLIS, Md., Sept. 18 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will present two ...

PharmAthene to Present at the UBS Global Life Sciences Conference on Thursday September 25, 2008

... ANNAPOLIS, Md., Sept. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that David P. Wright, President and...

PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration

... ANNAPOLIS, Md., Sept. 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, annou...

PharmAthene Reports Second Quarter 2008 Financial and Operational Results

... On Track to Reach Significant Milestones in Second Half 2008 ANNAPOLIS, Md., Aug. 12 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene

...ies for the Company's Medical Countermeasures ANNAPOLIS, Md., Aug. 11 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that Lord Lewis Moonie has joined ...

PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel

...ANNAPOLIS, Md., July 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercializatio...sion into broader markets." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Reports First Quarter 2008 Financial Results

... ANNAPOLIS, Md., May 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica..., or until June 13, 2008. About PharmAthene, Inc. PharmAthene's (Amex: pip ) mission is to be the premier company worldwide specializing in the develo...

PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008

... ANNAPOLIS, Md., May 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...pproximately June 13, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed in March 2001 with a mission to become the premier company wor...

PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit

...IS, Md., April 2, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...e against anthrax threats." About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Reports Year-End 2007 Financial Results

...NNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...proximately April 30, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program

...NAPOLIS, Md., March 26 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company specializing in the development and commercializatio...hich are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008

...NAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica...ys, or until April 30, 2008. About PharmAthene, Inc PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene to Delay Release of Full Year 2007 Financial Results

...NNAPOLIS, Md., March 20 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biologica...on announced earlier today. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia

...e website. The webcast will be available for 30 days, or until approximately Thursday, April 17, 2008. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference

...NAPOLIS, Md., March 10 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008

...sified as either G-agents (sarin, soman, tabun) or V-agents (VX), both of which are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations

...aduate of the University of Pittsburgh where she received a Ph.D. in Microbiology/Biological Sciences. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biologic...

PharmAthene to Present at the BIO CEO & Investor Conference 2008

...ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... Jurchison at 410-269-2610. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthene's Legal Action in Breach of Contract Lawsuit Against SIGA

...NNAPOLIS, Md., Jan. 16 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing medical countermeasures against biologica... the treatment of smallpox. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services

...NNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company specializing in the development and commercializati...ecuted agreement is received. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its Allies...

Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court

... ANNAPOLIS, Md., Aug. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: pip ) a biodefense company developing and commercializing medical countermeasures against biological and chemical threats, announced today that proceeding...

Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.

... ANNAPOLIS, Md., Aug. 17 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) announced today that a hearing has been scheduled by the Delaware Court of Chancery for 2:00 p.m. on Monday, August 27, 2007, in an action filed by ...

Technology changing for better, Coburn says

... Madison, Wis. - pip Coburn offers a different framework for selling products to what he calls, in a tongue-in-cheek manner, "real humans." And given his forecasting credi...
Other Tags
(Date:9/22/2014)... fishes that manufacture their own "antifreeze" proteins to ... an unfortunate side effect, researchers report: The protein-bound ... melting even when temperatures warm. , The ... the National Academy of Sciences . , "We ... of the evolution of antifreeze proteins in Antarctic ...
(Date:9/22/2014)... CITY (September 22, 2014)The Brain & Behavior ... award of NARSAD Young Investigator Grants valued ... of the world,s most promising young scientists. ... groundbreaking neurobiological research will seek to identify ... for psychiatric disorders that affect one in ...
(Date:9/22/2014)... much more useful in homes, if they could locate ... world with cameras and lasers, which have difficulty reliably ... in clutter. A complementary way robots can "sense" what ... ultra-high frequency radio-frequency identification (UHF RFID) tags. Inexpensive self-adhesive ... robot to search a room for the correct tag,s ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3
(Date:9/22/2014)... York (PRWEB) September 22, 2014 ... the use of power morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) ... a new report detailing the continued use of ... federal regulators that specifically discouraged these procedures. According ... that the potential cancer risks associated with power ...
(Date:9/22/2014)... Gray HealthDay Reporter MONDAY, ... woman wonders: What can I do to help ensure a ... as prescribed may play a role in reducing the risk ... The researchers found that mothers of children with autism were ... during pregnancy than those whose children seem to be developing ...
(Date:9/22/2014)... In a continued effort to support ... is launching an awareness campaign inspired by the ice ... aims to raise awareness and funds for the cause. ... in the air and trying to catch it while ... a nominee does not complete the challenge within 24 ...
(Date:9/22/2014)... Ind. Researchers have developed a chip capable ... use the new system to test the effectiveness ... new system, called a tumor-microenvironment-on-chip (T-MOC) device, will ... tumors and the barriers that prevent the targeted ... Purdue University associate professor of mechanical engineering., Researchers ...
(Date:9/22/2014)... 22, 2014 The New York Group ... Surgery at the Icahn School of Medicine at Mount ... Group for Plastic Surgery gives residents of New York ... team of world-renowned plastic surgeons performing innovative reconstructive and ... MD, who led NYGPS, was named the Director of ...
Breaking Medicine News(10 mins):Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2Health News:New chip promising for tumor-targeting research 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3
Other Contents